These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 17049676

  • 1. The identification of two protective DNA vaccines from a panel of five plasmid constructs encoding Brucella melitensis 16M genes.
    Commander NJ, Spencer SA, Wren BW, MacMillan AP.
    Vaccine; 2007 Jan 02; 25(1):43-54. PubMed ID: 17049676
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the immunogenicity and the protective efficacy in mice of a DNA vaccine encoding SP41 from Brucella melitensis.
    Al-Mariri A, Abbady AQ.
    J Infect Dev Ctries; 2013 Apr 17; 7(4):329-37. PubMed ID: 23592643
    [Abstract] [Full Text] [Related]

  • 3. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
    Cloeckaert A, Jacques I, Grilló MJ, Marín CM, Grayon M, Blasco JM, Verger JM.
    Vaccine; 2004 Jul 29; 22(21-22):2827-35. PubMed ID: 15246618
    [Abstract] [Full Text] [Related]

  • 4. Induction of immune response in mice with a DNA vaccine encoding outer membrane protein (omp31) of Brucella melitensis 16M.
    Gupta VK, Rout PK, Vihan VS.
    Res Vet Sci; 2007 Jun 29; 82(3):305-13. PubMed ID: 17014873
    [Abstract] [Full Text] [Related]

  • 5. A DNA vaccine coding for the chimera BLSOmp31 induced a better degree of protection against B. ovis and a similar degree of protection against B. melitensis than Rev.1 vaccination.
    Cassataro J, Pasquevich KA, Estein SM, Laplagne DA, Zwerdling A, de la Barrera S, Bowden R, Fossati CA, Giambartolomei GH, Goldbaum FA.
    Vaccine; 2007 Aug 10; 25(32):5958-67. PubMed ID: 17600596
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of immunogenicity and protective activity in BALB/c mice of the 25-kDa major outer-membrane protein of Brucella melitensis (Omp25) expressed in Escherichia coli.
    Bowden RA, Cloeckaert A, Zygmunt MS, Dubray G.
    J Med Microbiol; 1998 Jan 10; 47(1):39-48. PubMed ID: 9449948
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of protective effect of DNA vaccines encoding the BAB1_0263 and BAB1_0278 open reading frames of Brucella abortus in BALB/c mice.
    Sislema-Egas F, Céspedes S, Fernández P, Retamal-Díaz A, Sáez D, Oñate A.
    Vaccine; 2012 Nov 26; 30(50):7286-91. PubMed ID: 23026687
    [Abstract] [Full Text] [Related]

  • 8. [Immunobiological characteristics of Brucella outer membrane proteins, genetic determinants of which are expressed in Escherichia coli cells].
    Seliutina DF, Malikov VE, Chibisova VA, Gorelov VN, Skavronskaia AG.
    Mol Gen Mikrobiol Virusol; 1993 Nov 26; (1):17-20. PubMed ID: 8510678
    [Abstract] [Full Text] [Related]

  • 9. Immunization of mice with recombinant S-adenosyl-L-homocysteine hydrolase protein confers protection against Brucella melitensis infection.
    Yang Y, Yin J, Guo D, Lang X, Wang X.
    FEMS Immunol Med Microbiol; 2011 Mar 26; 61(2):159-67. PubMed ID: 21166726
    [Abstract] [Full Text] [Related]

  • 10. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.
    Winter AJ, Schurig GG, Boyle SM, Sriranganathan N, Bevins JS, Enright FM, Elzer PH, Kopec JD.
    Am J Vet Res; 1996 May 26; 57(5):677-83. PubMed ID: 8723881
    [Abstract] [Full Text] [Related]

  • 11. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R, Contreras A, Sanakkayala N, Sriranganathan N, Boyle SM, Schurig GG.
    Vet Microbiol; 2004 Sep 08; 102(3-4):237-45. PubMed ID: 15327798
    [Abstract] [Full Text] [Related]

  • 12. Cloning of a Brucella melitensis group 3 antigen gene encoding Omp28, a protein recognized by the humoral immune response during human brucellosis.
    Lindler LE, Hadfield TL, Tall BD, Snellings NJ, Rubin FA, Van De Verg LL, Hoover D, Warren RL.
    Infect Immun; 1996 Jul 08; 64(7):2490-9. PubMed ID: 8698471
    [Abstract] [Full Text] [Related]

  • 13. Brucella melitensis 16MΔhfq attenuation confers protection against wild-type challenge in BALB/c mice.
    Zhang J, Guo F, Chen C, Li Z, Zhang H, Wang Y, Zhang K, Du G, Li Y, Wang J, Jian T, Wang Z.
    Microbiol Immunol; 2013 Jul 08; 57(7):502-10. PubMed ID: 23647412
    [Abstract] [Full Text] [Related]

  • 14. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
    Golshani M, Rafati S, Siadat SD, Nejati-Moheimani M, Shahcheraghi F, Arsang A, Bouzari S.
    Mol Immunol; 2015 Aug 08; 66(2):384-91. PubMed ID: 25968974
    [Abstract] [Full Text] [Related]

  • 15. A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.
    Cassataro J, Pasquevich KA, Estein SM, Laplagne DA, Velikovsky CA, de la Barrera S, Bowden R, Fossati CA, Giambartolomei GH, Goldbaum FA.
    Vaccine; 2007 May 30; 25(22):4437-46. PubMed ID: 17442465
    [Abstract] [Full Text] [Related]

  • 16. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
    Li ZQ, Shi JX, Fu WD, Zhang Y, Zhang J, Wang Z, Li TS, Chen CF, Guo F, Zhang H.
    Mol Immunol; 2015 Aug 30; 66(2):276-83. PubMed ID: 25899866
    [Abstract] [Full Text] [Related]

  • 17. B. melitensis rough strain B115 is protective against heterologous Brucella spp. infections.
    Adone R, Francia M, Pistoia C, Pesciaroli M, Pasquali P.
    Vaccine; 2011 Mar 21; 29(14):2523-9. PubMed ID: 21300102
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Induction of immune response in BALB/c mice with a DNA vaccine encoding bacterioferritin or P39 of Brucella spp.
    Al-Mariri A, Tibor A, Mertens P, De Bolle X, Michel P, Godfroid J, Walravens K, Letesson JJ.
    Infect Immun; 2001 Oct 21; 69(10):6264-70. PubMed ID: 11553569
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections.
    Adone R, Francia M, Ciuchini F.
    Vaccine; 2008 Sep 08; 26(38):4913-7. PubMed ID: 18675869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.